ICD-10 Coding for Triple-Negative Breast Cancer(C50.411, C50.411B, C50.411M)
Learn how to accurately code and document triple-negative breast cancer using ICD-10 codes, including C50 and Z17.01.
Complete code families applicable to Triple-Negative Breast Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast | Use when the tumor is located in the upper-outer quadrant of the right breast. |
|
| Z17.01 | Estrogen receptor negative, progesterone receptor negative, HER2 negative status | Use to specify triple-negative receptor status in breast cancer. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutTriple-Negative Breast Cancer
Alternative codes to consider when ruling out similar conditions
Use when specific tumor location and receptor status are not documented.
Documentation & Coding Risks
Avoid these common issues when documenting Triple-Negative Breast Cancer.
Omitting receptor status in documentation
Impact
Clinical: Misrepresentation of cancer type, Regulatory: Non-compliance with coding standards, Financial: Potential reimbursement issues
Mitigation
Ensure all pathology reports include receptor status, Regular audits of documentation
Using C50.9 without specifying receptor status
Impact
Reimbursement: May result in incorrect DRG assignment, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation
Always pair with Z17.01 to indicate triple-negative status.
Receptor status documentation
Impact
Failure to document receptor status can lead to audit issues.
Mitigation
Implement regular documentation audits and training.